Literature DB >> 22063383

Sex and pain perception and analgesia.

Cláudia Carneiro de Araújo Palmeira1, Hazem Adel Ashmawi, Irimar de Paula Posso.   

Abstract

Sex is an important factor in painful experience modulation. Large volume of evidence shows that experience is different for males and females, as well as the answer to some classes of analgesics. Laboratory experiments suggest that women have a lower pain threshold than men related to pain from noxious stimuli such as heat, cold, pressure and electrical stimulation. Pain is a dynamic phenomenon under the influence of various mechanisms of excitatory and inhibitory control. The differences in pain perception related to sex may be associated with hyperalgesia in women, but also to the hypoactivity of the inhibitory system of pain in females. The purpose of this review besides showing some relationship for gonadal hormones, central nervous system and pain is to provide reference points for the discussion of one of the most intriguing aspects of the pathophysiology of pain: the differences in the presence of painful stimuli related to gender. Copyright Â
© 2011 Elsevier Editora Ltda. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22063383     DOI: 10.1016/S0034-7094(11)70091-5

Source DB:  PubMed          Journal:  Rev Bras Anestesiol        ISSN: 0034-7094            Impact factor:   0.964


  18 in total

1.  Antinociceptive effects of sinomenine in a rat model of postoperative pain.

Authors:  Qing Zhu; Yuehua Sun; Lina Mao; Chengpeng Liu; Bo Jiang; Wei Zhang; Jun-Xu Li
Journal:  Br J Pharmacol       Date:  2016-03-31       Impact factor: 8.739

2.  In vivo and in vitro comparison of female and male nociceptors.

Authors:  Jan Hendrich; Pedro Alvarez; Elizabeth K Joseph; Luiz F Ferrari; Xiaojie Chen; Jon D Levine
Journal:  J Pain       Date:  2012-11-10       Impact factor: 5.820

3.  The effectiveness of photobiomodulation in the management of temporomandibular pain sensitivity in rats: behavioral and neurochemical effects.

Authors:  Alex de Freitas Rodrigues; Daniel de Oliveira Martins; Marucia Chacur; João Gualberto C Luz
Journal:  Lasers Med Sci       Date:  2019-07-10       Impact factor: 3.161

4.  Estradiol Acts in Lateral Thalamic Region to Attenuate Varicella Zoster Virus Associated Affective Pain.

Authors:  Crystal Stinson; Shaun M Logan; Larry L Bellinger; Mahesh Rao; Paul R Kinchington; Phillip R Kramer
Journal:  Neuroscience       Date:  2019-07-02       Impact factor: 3.590

Review 5.  Pain and thyroid hormones.

Authors:  Anna Maria Aloisi; Stella Vodo; Michelangelo Buonocore
Journal:  Neurol Sci       Date:  2013-04-23       Impact factor: 3.307

6.  Cutaneous allodynia in patients with episodic migraine.

Authors:  Hayat Güven; Aslı Ece Çilliler; Selim Selçuk Çomoğlu
Journal:  Neurol Sci       Date:  2012-11-23       Impact factor: 3.307

7.  A Review of Strain and Sex Differences in Response to Pain and Analgesia in Mice.

Authors:  Jennifer C Smith
Journal:  Comp Med       Date:  2019-12-10       Impact factor: 0.982

8.  Safety and efficacy of sufentanil combined with midazolam in bronchoscopy under conscious sedation: retrospective study of 11,158 cases.

Authors:  Yao Yao; Zhuquan Su; Yu Chen; Yongshun Ye; Liya Lu; Changhao Zhong; Xiaobo Chen; Chunli Tang; Shiyue Li
Journal:  J Thorac Dis       Date:  2019-10       Impact factor: 2.895

9.  Role of sex hormones in modulating breast and ovarian cancer associated pain.

Authors:  Melissa C McHann; Henry L Blanton; Josée Guindon
Journal:  Mol Cell Endocrinol       Date:  2021-05-24       Impact factor: 4.369

10.  FLOX (5-fluorouracil + leucovorin + oxaliplatin) chemotherapy for colorectal cancer leads to long-term orofacial neurotoxicity: a STROBE-guided longitudinal prospective study.

Authors:  Priscilla de Albuquerque Ribeiro Gondinho; Paulo Goberlânio de Barros Silva; Mário Roberto Pontes Lisboa; Bruno Almeida Costa; Duílio Reis da Rocha Filho; Markus Andret Cavalcante Gifoni; Marcos Venicio Alves Lima; Roberto César Pereira Lima Junior; Mariana Lima Vale
Journal:  Int J Clin Oncol       Date:  2020-08-06       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.